Article
P53 mutation predicts intravesical adriamycin instillation failure in superficial transitional cell carcinoma of bladder.
Anticancer research - 1 Jan 2000
Shiraishi Koji, Eguchi Satoshi, Mohri Jun, Kamiryo Yoriaki
Abstract excerpt
BACKGROUND: We studied whether p53 status has any predictive value on the outcome of intravesical adriamycin (ADR) instillation for superficial transitional cell carcinoma (TCC) of the bladder. MATERIALS AND METHODS: Paraffin-embedded specimens were obtained from 70 consecutive patients by transurethral resection (TUR). All patients received intravesical instillation with either Epirubicin (n = 45) or Pirarubicin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.